UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

mRNA Vaccines in the COVID-19 Pandemic and Beyond

Annual review of medicine, 2022-01, Vol.73 (1), p.17-39

2022

Volltextzugriff (PDF)

mRNA Innovates the Vaccine Field

Vaccines (Basel), 2021-05, Vol.9 (5), p.486

Pardi, Norbert

2021

Volltextzugriff (PDF)

Development of vaccines and antivirals for combating viral pandemics

Nature biomedical engineering, 2020-12, Vol.4 (12), p.1128-1133

2020

Volltextzugriff (PDF)

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Nature biotechnology, 2021-08, Vol.39 (8), p.949-957

2021

Volltextzugriff (PDF)

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Nature communications, 2021-01, Vol.12 (1), p.613-10, Article 613

2021

Volltextzugriff (PDF)

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Journal of controlled release, 2015-11, Vol.217, p.345-351

2015

Volltextzugriff (PDF)

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

Molecular therapy, 2022-05, Vol.30 (5), p.1941-1951

2022

Volltextzugriff (PDF)

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Cell host & microbe, 2021-01, Vol.29 (1), p.23-31.e4

2021

Volltextzugriff (PDF)

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

Science (American Association for the Advancement of Science), 2021-08, Vol.373 (6558), p.991-998

2021

Volltextzugriff (PDF)

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Nature communications, 2018-08, Vol.9 (1), p.3361-12, Article 3361

2018

Volltextzugriff (PDF)

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Nature communications, 2017-03, Vol.8 (1), p.14630-8, Article 14630

2017

Volltextzugriff (PDF)

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

Nature communications, 2021-06, Vol.12 (1), p.3460-18, Article 3460

2021

Volltextzugriff (PDF)

New Kids on the Block: RNA-Based Influenza Virus Vaccines

Vaccines (Basel), 2018-04, Vol.6 (2), p.20

2018

Volltextzugriff (PDF)

PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

Journal of controlled release, 2018-12, Vol.291, p.106-115

2018

Volltextzugriff (PDF)

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Nature communications, 2022-08, Vol.13 (1), p.4677-14, Article 4677

2022

Volltextzugriff (PDF)

Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)

Journal of controlled release, 2022-04, Vol.344, p.50-61

2022

Volltextzugriff (PDF)

Nucleoside-Modified mRNA Vaccines Protect IFNAR -/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection

Journal of virology, 2022-02, Vol.96 (3), p.e0156821

2022

Volltextzugriff (PDF)

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Nature communications, 2021-05, Vol.12 (1), p.2825-2825, Article 2825

2021

Volltextzugriff (PDF)

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

PLoS pathogens, 2020-07, Vol.16 (7), p.e1008795-e1008795

2020

Volltextzugriff (PDF)

DELAYED INTRASPINAL DELIVERY OF MRNAS ENCODING A COMBINATION OF CYTOKINES AND GDNF PROMOTES MORPHOLOGICAL AND FUNCTIONAL RECOVERY FOLLOWING SPINAL CORD INJURY

IBRO neuroscience reports, 2023-10, Vol.15, p.S177-S177

2023

Volltextzugriff (PDF)

Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice

Nature communications, 2024-06, Vol.15 (1), p.5010-12

2024

Volltextzugriff (PDF)

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

npj vaccines, 2021-06, Vol.6 (1), p.84-84, Article 84

2021

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

mRNA Vaccines in the COVID-19 Pandemic and Beyond

mRNA Innovates the Vaccine Field

Development of vaccines and antivirals for combating viral pandemics

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge

Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

New Kids on the Block: RNA-Based Influenza Virus Vaccines

PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)

Nucleoside-Modified mRNA Vaccines Protect IFNAR -/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection

Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

DELAYED INTRASPINAL DELIVERY OF MRNAS ENCODING A COMBINATION OF CYTOKINES AND GDNF PROMOTES MORPHOLOGICAL AND FUNCTIONAL RECOVERY FOLLOWING SPINAL CORD INJURY

Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice

Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates

Aktive Filter

Suchergebnisse filtern